|Articles|June 1, 2006

Pharmacy Times

  • Volume 0
  • 0

LONG-TERM WARFARIN USE MAY INCREASE RISK OF FRACTURES IN MEN

A study of Medicare beneficiaries with atrial fibrillation whowere hospitalized between March 1998 and April 1999throughout the country found that men who were on longterm(defined as >1 yr) warfarin therapy were 63% more likelyto suffer an osteoporosis-related fracture of the hip, spine,or wrist.Women on long-term therapy and patients who tookthe drug for <1 year had no significant increase in risk.

Vitamin K is involved in the activation of bone proteins.Warfarin's inhibition of this activation process because ofvitamin K antagonism may explain why patients on long-term therapy face anincreased risk of osteoporosis. The study also found that patients who were onbeta-blockers or who had high dietary intake of vitamin K and folate had adecreased risk of fractures.

Dr. Garrett is a clinical pharmacist practitionerat Cornerstone Health Care in HighPoint, NC.

Articles in this issue

over 19 years ago

can you READ these Rxs?

over 19 years ago

case STUDIES

over 19 years ago

Compounding HOTLINE

over 19 years ago

RESPy AWARD

over 19 years ago

Compounding for Prenatal Patients

over 19 years ago

Prescription Monitoring Programs

over 19 years ago

FMEA Can Help Prevent Errors

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME